AIM ImmunoTech News

AIM ImmunoTech Adjusts Executive Compensation and Agreements

TipRanksSep 12 17:18 ET

Express News | AIM ImmunoTech-Cash Portion of Equels' Short-Term Compensation Was Reduced From $750,000 to $650,000

ReutersSep 12 16:48 ET

Express News | AIM ImmunoTech- Compensation Committee of Board Reviewed Compensation Arrangements of CEO Thomas K. Equels

ReutersSep 12 16:47 ET

Advyzon Investment Management (AIM) Wins WealthManagement.com Industry Award for Model Marketplaces

BusinesswireSep 12 07:03 ET

Express News | Todd Deutsch: Ted Kellner Supplemented Previously Submitted Notice of Intent of Nominations to AIM ImmunoTech Board - SEC Filing

ReutersSep 11 17:48 ET

AIM ImmunoTech Announces That Analysis Of AMP-518 Complete Clinical Patient Data Underscores Ampligen's Potential To Improve The Post-COVID Condition Of Fatigue, And That This Would Be The Likely Subject Population For AIM's Planned Follow-up Clinical...

BenzingaSep 11 09:01 ET

AIM ImmunoTech Analyst Ratings

BenzingaSep 3 06:07 ET · Ratings

Express News | AIM ImmunoTech Inc : Ascendiant Capital Markets Cuts Target Price to $5 From $5.25

ReutersSep 2 02:40 ET

AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.

BenzingaAug 20 15:22 ET

Express News | AIM ImmunoTech Announces Print Publication and Further Positive Findings From a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

ReutersAug 20 08:30 ET

AIM ImmunoTech Announces Print Publication and Further Positive Findings From a Study Evaluating Ampligen in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

AIM ImmunoTechAug 20 00:00 ET

Earnings Call: AIM ImmunoTech Reports Progress in Clinical Trials

InvestingAug 16 13:10 ET

AIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call Transcript Summary

moomoo AIAug 16 11:51 ET · Conference Call

Express News | AIM ImmunoTech Inc- Qtrly Shr Loss $0.03

ReutersAug 16 07:04 ET

AIM ImmunoTech GAAP EPS of -$0.03 Beats by $0.10

Seeking AlphaAug 16 07:03 ET

AIM ImmunoTech 2Q Loss/Shr 3c >AIM

Dow JonesAug 16 07:01 ET

AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update

AIM ImmunoTechAug 16 00:00 ET

AIM ImmunoTech | 10-Q: Q2 2024 Earnings Report

SECAug 14 17:05 ET · Announcements

Express News | Todd Deutsch: Ted Kellner Intends to Submit Notice to AIM ImmunoTech Well in Advance of Deadline of Sept 13, 2024

ReutersAug 14 07:45 ET

Express News | Todd Deutsch: Ted Kellner Plans to Submit to AIM ImmunoTech Notice of Intent to Nominate Himself, Todd Deutsch,Chioini for Election to Co’s Board

ReutersAug 14 07:44 ET